For months, legislators have chipped away at President Joe Biden’s Build Back Better Act, with the resulting leftovers centering around lowering drug costs for Medicare and Medicaid beneficiaries, according to The Washington Post.
Read the full post on Becker's Hospital Review - Healthcare News
